Marjana Tomic-Canic PhD
Professor, University of Miami Miller School of Medicine
Department of Dermatology
1600 NW 10th Avenue
Rosenstiel Medical Science Building – Room 2023-A
Miami, FL 33136
Dr Tomic-Canic is a Professor of Dermatology and Director of Wound Healing and Regenerative Medicine Research Program at the University Of Miami Miller School Of Medicine. She is also a senior faculty member of the Human Genetics & Genomics and Molecular & Cellular Pharmacology Programs and Associate Member of the Hussman Genomics Institute at the University of Miami. She received her doctoral and postdoctoral training at the NYU School of Medicine and joined the faculty of NYU Departments of Dermatology and Microbiology. As a faculty member of the Weill Medical College of the Cornell University she directed Tissue Repair Program at the Department of Tissue Engineering, Repair and Regeneration of Hospital for Special Surgery before moving to University of Miami in 2008. She is recognized national and international leader in the field of wound healing research and was recently recognized by National Institutes of Health with WALS Lectureship and was appointed to Advisory Council of the NIH/NINR. Her research has been continuously funded by NIH for many years. In addition, her laboratory received support from DOD, ADA, National Pressure Ulcer and Dermatology Foundation and industry-sponsored research grants. Current research is focused in three main areas: molecular and cellular mechanisms of wound healing and its inhibition, including epigenetic and genomic regulation (with long term goals to develop both novel therapeutics and wound diagnostics); anti-inflammatory processes in cutaneous wound healing (mechanisms by which steroids and cholesterol metabolism regulate healing) and wound infection and mechanisms of host response. Dr Tomic-Canic has participated in national scientific and clinical panels discussing the immense need for translational research areas to improve clinical outcomes of wound healing. Also, she is a member of the Editorial Board of the Journal of Biological Chemistry and an Associate Editor of the Journal of Investigative Dermatology. She is a member of the Wound Healing Society (WHS) since 2000, she served on the Website, Publications, Government Relations, and Nominations Committees. In addition, she Chaired Program Committee (organized Annual WHS meeting in 2011) and served as a member of the Board of Directors 2011-2013.
President Elect (2016-2017)
Elof Eriksson, MD, PhD
Chief, Division of Plastic Surgery
Brigham & Women's Hospital
75 Francis Street
Boston, MA 02115
Elof Eriksson was born in Sweden, and received his graduate medical and research training there. He then completed a general surgery residency at the University of Chicago, and a plastic surgery residency at the Medical College of Virginia. Subsequently he returned to Sweden and worked for three years in Gothenburg. He then returned to the US to be the Director of the Burn Center at Memorial Medical Center at SIU in Springfield, IL. Since 1986 he has been the Chief of Plastic Surgery at Brigham and Women’s Hospital, Harvard Medical School. In 1997, he became the first Joseph E. Murray Professor of Plastic and Reconstructive Surgery. His early research dealt with microcirculation in muscle and skin. Later he focused on wound repair using gene transfer to modify signaling. The current focus is on the analysis and modification of the wound microenvironments as well as keratinocyte and fibroblast transplantation for regeneration of skin. He has published more than 150 peer reviewed papers on Wound Healing. When he was President of the Wound Healing Foundation from 2002 – 2004, he initiated, raised the necessary funds, and helped oversee the WHS Wound Healing Guidelines project.
Vice President (2016-2017)
Sashwati Roy, Ph.D.
Associate Professor, The Ohio State University
473 West 12th Avenue
Columbus, OH 43210
Sashwati Roy, PhD is an Associate Professor of Surgery and Director of laser capture Molecular Analysis facility at the Ohio State University Columbus Ohio. She received her PhD in 1994 in Physiology and Environmental Sciences. She completed her postdoctoral training from University of California, Berkeley. Her research interest include wound inflammation, mechanisms of resolution of diabetic wound inflammation, role of miRNA in tissue repair processes. Dr. Roy has over 150 peer review publications in high impact journals including PNAS and Journal of Immunology. She serves in the Editorial Board of several Journals such as Physiological Genomics, Antioxidants and Redox Signaling. She is an expert in significance of macrophage and inflammation in chronic wounds. Dr. Roy has recently served as a program co-chair for the annual (2013) meeting of the Wound Healing Society held in Denver, CO. She is currently appointed as the secretary for the Society. Dr. Roy’s research is funded by National Institute of Health (NIDDK, NIH) to investigate on the role of inflammation in diabetic wounds. She also serves as a co-investigator on multiple federal (NIH, DOD and VA) grants on miRNA and wound healing.
Traci Wilgus, Ph.D
The Ohio State University
1645 Neil Avenue
129 Hamilton Hall
Columbus, OH 43210
Dr. Wilgus is an Assistant Professor in the Department of Pathology at The Ohio State University. She earned her Ph.D. from Ohio State and completed post-doctoral training at Loyola University Medical Center. She was a junior faculty member at University of Illinois-Chicago before accepting a tenure-track position at Ohio State in 2008. Her lab studies the role of inflammation and angiogenesis in wound healing and skin carcinogenesis, and is particularly interested in scarless fetal healing. She currently receives funding from two NIH grants. Dr. Wilgus is an ad hoc reviewer for NIH and US Army research grants, and a permanent member of the Wound panel for the Military Infectious Diseases Research Program.
Dr. Wilgus joined the Wound Healing Society as a graduate student in 2000. She served on the Website Committee (2008-2011) and is currently a member of the Awards and Program Committees. For the past five years, she has reviewed abstracts, served as a moderator, and helped organized the Meet the Mentors session for the annual meeting. She frequently reviews manuscripts for the WHS journals Wound Repair and Regeneration and Advances in Wound Care, and sits on the editorial boards for Ostomy Wound Management and Advances in Wound Care.
Braham Shroot, PhD
1810 Barclay Boulevard,
Princeton, NJ 08540
Currently the CEO of Signum Biosciences, a private biotechnology company dedicated to developing small-molecule therapeutics derived from its Signal Transduction Modulation (STM) platform to modulate signal transduction imbalances.
Braham Shroot is the former CSO of Barrier Therapeutics, Inc., a public dermatology-focused pharmaceutical company, which was acquired by Stiefel Laboratories Inc., in August 2008. Prior to Barrier, Dr. Shroot was CSO and Vice President of R&D for DFB Pharmaceuticals, Inc., a fully integrated private specialty pharmaceutical company with a focus on skin, wound care, and surgical markets. Before DFB, Dr. Shroot was at L'Oreal where he was Group Leader and eventually Vice General Manager of the newly created Galderma entity which he helped to establish. Dr. Shroot earned his B.Sc. in Chemistry and Ph.D. in Organic Chemistry at Glasgow University, Scotland, UK. He is also a board member of the Wound Healing Society, and associate Editor of the Journal of Investigative Dermatology.
Past President (2016-2017)
Andrew Baird, Ph.D
Professor, University of California San Diego
Department of Surgery
Division of Trauma, Burns and Wounds
200 Arbor Drive, MC 8236
San Diego, CA 92103
Trained in Biochemistry (PhD, 1980) at McGill University in Montreal Canada, Dr Baird started as a postdoctoral fellow at the Salk Institute with Roger Guillemin (Nobel,1977) in the early 1980s where he remained as junior faculty to 1989. At the Salk Institute, he carried out basic research on the control of cell growth and function that was to lead towards the first isolation and characterization of the first-ever angiogenic factor called basic fibroblast growth factor (FGF2). Later, at the Salk Institute and subsequently with The Scripps Research Institutes in San Diego, California, he was involved in characterizing the FGF high affinity receptor, sequencing the FGF low affinity receptor (heparan sulfate), identifying the FGF2 promoter, generating the first transgenic mouse over expressing the FGF gene and establishing the first structure-function studies characterizing FGF2 ligand-receptor interactions. With this information, he identified a series of FGF2 agonists and antagonists for wound healing. In 1995, he closed his academic laboratories and moved into the biotechnology sector, where for 7 years (1995-2001), he learned the process of pre-IND drug development including QA/QC, cGMP, manufacture and process development in the hope of better understanding why growth factors were not the huge biotherapeutic successes in angiogenesis, wound healing and tissue repair that were expected when first discovered. This experience turned his attention to the unique challenges of drug delivery for wound healing therapeutics and specifically, the temporal-spatial needs for multiple factors at multiple times. To this end he helped turn the company s research program from protein to gene therapeutics while developing new vectors for gene delivery, identifying new modes of gene targeting and discovering a small molecule inhibitor of macrophage migration inhibiting factor (MIF) that is currently in drug development by Novartis. In 2001, he returned to academia with a continued interest in drug discovery, development and deployment for injury and tissue repair. His laboratories currently work on drug delivery for wound healing and the development of techniques that can identify genes of the therapeutome : genes that encode proteins with direct and intrinsic therapeutic value to tissue repair. He currently leads an NIH Exploratory Center for Innovative Wound Healing Research in the Department of Surgery at University of California San Diego.
Adrian Barbul, MD (2016-2019)
Vanderbilt University School of Medicine
1161 21st Avenue South
D-5203 Medical Center North
Nashville, TN 37232-2577
A native of Romania, Dr. Barbul graduated from the School of General Medicine in Bucharest Romania. He began his surgical residency at the Albert Einstein College of Medicine where he also completed a two year Research Fellowship in Burns and Trauma. He completed his residency at Sinai Hospital of Baltimore while also running a very productive basic science laboratory. After his residency Dr. Barbul practiced as a General and Trauma Surgeon while also establishing a wound healing research laboratory examining the influence of amino acid nutrition and immunity of the healing cascade. He has more than 30 years of experience in the study of wound healing. Although his expertise includes many of the subdiciplines of wound healing, he is perhaps most well known for his study of the role of nutrition and amino acids in wound healing.
Dr. Barbul has authored over 180 original publications, over 50 textbook chapters and has edited two books. He has presented extensively as an invited Grand Rounds presenter or at international meetings. As founding member and then as President of the Wound Healing Society, he led a team charged with the promulgation of care guidelines for arterial, diabetic, venous and pressure ulcers which have been widely disseminated, accepted and adopted.
Academically, Dr. Barbul is Professor of Surgery at the Vanderbilt University School of Medicine.
Robert D. Galiano, MD, FACS (2015-2018)
Associate Professor, Director of Research
Div of Plastic Surgery
Northwestern University Feinberg School of Medicine
675 N. St. Clair Street
Chicago, IL 60611
Rob Galiano is a native of Quito, Ecuador, and grew up in Chicago. He first joined the Wound Healing Society as a medical student when he worked in Tom Mustoe’s laboratory at Northwestern University. Following medical school, he did his combined plastic surgery/general surgery residency at NYU Medical Center under the chairmanship of Dr. Joseph McCarthy. He did a 3-year postdoctoral fellowship in the lab of Dr. Geoff Gurtner, where he worked on the impact that diabetes has on hypoxia-induced signaling pathways, and where he also developed the mouse splinted wound model. He returned to Northwestern University Feinberg School of Medicine in 2006, and has been at Northwestern since that time. He currently is an Associate Professor and Director of Research in the Division of Plastic Surgery. The majority of his clinical practice is dedicated to the care of patients with complex wounds. A dedicated surgeon-scientist, he directs the Laboratory for Tissue Repair and Regenerative Surgery, and his work centers on models of biofilm, scarring, diabetic healing and in-vivo tissue engineering with the use of implantable bioreactors. Along with co-Directors Tom Mustoe and Jay Hong, the lab participates in the AFIRM II Consortium and has 2 projects funded by this DOD-run group. He also runs a productive Clinical Trials Unit, and has participated in more than 20 industry-sponsored clinical trials in areas of wound healing, scarring and plastic surgery. He also has initiated several outcome-based studies examining economic impact of wound healing technologies as well as disparities in wound care. He is on the editorial boards of the journals Plastic and Reconstructive Surgery, the Journal of Surgical Research, and Ostomy and Wound Management, and is a frequent ad-hoc reviewer of other wound healing journals. He has published nearly 100 articles, reviews and book chapters and edited the textbook Current Therapy in Plastic Surgery. He has been the recipient of approximately $6 million in research funding in wound healing, tissue engineering and scarring projects, and has mentored approximately 30 students, residents and postdoctoral fellows in the field of wound healing. He currently serves on the Program Committee of WHS as well as multiple committees in other societies. He hopes to “give back” to WHS with his service. His goal is to leverage his passion for wound healing and utilize collaborations with industry, academia, and government colleagues in order to enhance the role that the Society has on both fundamental research in tissue repair as well as translational and educational initiatives that derive from our collective expertise.
Harriet W. Hopf, MD (2015-2018)
Professor and Vice Chair
Department of Anesthesiology
Associate Dean for Academic Affairs
University of Utah School of Medicine
Room 3C444, 30 N 1900 East
Salt Lake City, UT 84132
Harriet W. Hopf, MD is Professor and Vice Chair for Faculty Development in the Department of Anesthesiology; Adjunct Professor of Bioengineering; and Associate Dean for Academic Affairs in the School of Medicine at the University of Utah. After receiving her BA from Yale and her MD from Dartmouth Medical School, she completed surgical internship at the University of Minnesota, anesthesia residency at UCSF, and research fellowships with TK Hunt in the Wound Healing Laboratory at UCSF. Her research focuses on preventing surgical site infections, improving research training in anesthesiology, and developing promotion and tenure policies that align with institutional mission and value.
Boris Hinz, PhD (2014-2017)
Associate Professor, University of Toronto
Matrix Dynamics Group, Faculty of Dentistry
Laboratory of Tissue Repair and Regeneration
Room 241, 150 College Street
Toronto, Canada M5S 3E2
Boris Hinz is Associate Professor at the Matrix Dynamics Group, Faculty of Dentistry, University of Toronto, Canada since 01/2009. He is cross-appointed Professor with the Faculty of Medicine, Department of Surgery and the Institute of Biomaterials and Biomedical Engineering at the University of Toronto. Dr. Hinz obtained his PhD degree in 1998 in Cell Biology and Theoretical Biology from the University of Bonn, Germany. The research of Dr. Hinz aims in understanding the role of contractile myofibroblasts in physiological tissue repair and in causing pathological tissue fibrosis. He published 71 peer reviewed articles, 10 book chapters, and >300 congress abstracts. His research lead to the creation of two startup companies specialized on anti-fibrotic coatings for silicone implants and novel “soft” cell culture devices. Dr. Hinz is Past President and board member of the European Tissue Repair Society (ETRS), Secretary and founding member of the Canadian Connective Tissue Society (CCTS), associate editor of the Journal Wound Repair. One of his contributions to the WHS board will be to intensify the long-standing relationship with the ETRS and establish new ties with the CCTS. As trained cell biologist, he has a particular interest to spark and mediate research activities between WHS members. This involves the facilitation of collaborations between laboratories in fundamental science and clinics.
Sundeep G. Keswani, MD, FACS, FAAP (2015-2018)
Associate Professor, Surgery & Pediatrics
Laboratory for Regenerative Wound Healing
Division of General & Thoracic Surgery
Cincinnati Children's Hospital Medical Center
3333 Burnet Ave, MLC 11025
Cincinnati, OH 45229
Sundeep Keswani is a practicing pediatric surgeon and director of the Pediatric Wound Care Center at the Cincinnati Children’s Hospital Medical Center. He also has an NIH funded lab that explores the underlying mechanisms of regenerative tissue repair. Sundeep has been actively involved with the WHS since 2002 and has served on the website committee, the annual task force committee, and has chaired the membership committee. Most recently, he was the co-chair for the WHS2015 annual meeting program in San Antonio. He is a past recipient of the WHS Young Investigator Award and the WHS Foundation’s 3M Fellowship. Sundeep is highly committed to the Wound Healing Society and vested in helping the society maintain and expand its role as the leading scientific group in the field of wound healing. .
Anie Philip, Ph.D. (2016-2019)
Montreal General Hospital
1650 Cedar Avenue
Montreal, QC H3G 1A4
514-934-1934 x44533 telephone
Anie Philip, PhD is a tenured Professor in the Department of Surgery at McGill University, Canada. She is also the Director of Plastic Surgery Research and Director of Experimental Surgery Graduate Program at McGill University, and Co-chair of the Skin Research Group Canada.
Dr Philip received her PhD from McGill and completed her post-doctoral training at the National Research Council Canada. She joined the Department of Surgery, McGill in 1994, and over the past 2 decades, her research program has focused on the molecular mechanisms of skin and cartilage repair and regeneration. Her research has been continuously funded by the Canadian Institutes of Health Research, NSERC Canada and more recently the Department of Defense USA. Her team’s recent contributions include the discovery and functional characterization of a novel TGF-b co-receptor, identification of unique regulatory mechanisms by TGF-b co-receptors in skin cells and chondrocytes. Her research is currently focused on developing novel anti-fibrotic peptides for which her team holds several patents.
Dr Philip has served the Wound Healing Society as the Annual Meeting Program Co-Chair (2010), Awards Committee Chair (2006-2009), Strategic Planning Committee member (2006-2011), and is currently a member of the Scientific Program and Website committees. As a Graduate Program Director at her University and a past WHS Awards Committee Chair, she has a special interest in advancing initiatives to promote the career development of WHS trainee members and retaining them in the area of wound healing research.
Heather Powell, Ph.D. (2016-2019)
The Ohio State University
116 W. 19th Avenue
243 Fontana Labs
Columbus, OH 43210
Heather Powell, PhD is currently an Associate Professor at The Ohio State University in the Departments of Materials Science and Engineering and Biomedical Engineering. During the majority of her academic career, she has focused on materials for burn repair and autologous tissue engineered skin, methods for reducing scarring post burn injury, and device development for non-destructive analysis of skin.
As a skin scientist with a non-traditional background in engineering, Heather brings a unique scientific perspective to the Board of Directors and will work to develop strategies to broaden the base of the members. “Efforts to increase the appeal of the Wound Healing Society for scientists with research focuses from translational medicine to technology will not only allow for more collaborative/networking opportunities within our society but also help adapt the WHS to meet the changing needs of our members.”
Katherine A. Radek, Ph.D. (2015-2018)
Loyola University, Chicago
Department of Surgery
2160 S 1st Ave
Building 110, Room 4237
Maywood, IL 60153
WHS History and Service: Katherine Radek has been a member of the WHS since 2005. She received her PhD from the laboratory of Luisa DiPietro, and completed her post-doctoral fellowship with Dr. Richard Gallo. She joined the Burn and Shock Trauma Research Institute at Loyola University Chicago in 2009 as a tenure-track Assistant Professor in the Department of Surgery, and was recently promoted to Associate Professor with tenure. She received the 3M WHSF Fellowship Award in 2012 for her research project entitled “Impairment of Epidermal Wound Healing Responses by the Cholinergic Anti-inflammatory Pathway”. Dr. Radek has also served on the WHS Program Committee since 2013 and has served as Chair of the WHS Website Committee since 2013. Over the past year, she and the rest of the WHS Website Committee members have been diligently working to make the WHS website more informative and easy to navigate, to improve website design and content, and to prioritize a list of preferred functionality enhancements. The WHS website is a continuous and influential entity in the wound care field that globally represents the Society. As a BOD member, I hope to better serve the wound healing community by identifying new research and fundraising opportunities for the WHS, increasing membership, and assisting with the legal and financial responsibilities of the WHS.
Current Research and Honors: Research in the Radek lab is designed to tease apart the epidermal α7 acetylcholine nicotinic receptor (nAChR) cholinergic microenvironment and elucidate how keratinocyte α7 nAChR activation influences Toll-like receptor 2-mediated inflammatory responses and antimicrobial peptides after skin injury and infection. A better fundamental understanding of how keratinocyte nAChRs regulate inflammatory responses during wound infection will expedite the development of new targeted treatment modalities to improve clinical care for uncontrolled inflammation and infection in chronic wound patients. Dr. Radek was the 2012 recipient of the Presidential Early Career Award for Scientists and Engineers (PECASE) via the NIH and United States Department of Health and Human Services for her work on cholinergic regulation of cutaneous antimicrobial peptide responses in relation to inflammatory skin diseases, and the 2014 recipient of the Loyola Junior Scientist of the Year Award.
Representing Wound Healing Society Foundation on the Board of Directors
Laura K.S. Parnell Ex-Officio
Founder & President
6522 Harbor Mist
Missouri City, TX 77459
Representing Wound Repair and Regeneration on the Board of Directors
Jeffrey M. Davidson, PhD Ex Officio
Editor in Chief, Wound Repair and Regeneration
Professor of Pathology, Microbiology and Immunology
Vanderbilt University School of Medicine
1161 21St. Ave. S
Nashville, TN 37232-2561
Brian Eliceiri, PhD Ex-Officio
Publications Committee Chair
Department of Surgery
University of California San Diego
212 Dickinson Street, MC 8236
San Diego, CA 92103